76
Mostly True
Europe
The website reports the launch of Quibim's QP-Breast MRI tool in Europe and the UK, designed to detect breast cancer more efficiently. It highlights the prevalence of breast cancer, the regulatory compliance of the tool, and the operational requirements of MRI scanners.
The claims regarding the launch and regulatory compliance of Quibim's QP-Breast MRI tool in Europe and the UK are well-supported by multiple sources, confirming its CE and UKCA marking. The prevalence of breast cancer as the most commonly diagnosed cancer in women globally is also corroborated by authoritative sources. However, the claim about the proportion of non-cancerous biopsied breast lesions lacks direct evidence, resulting in a lower confidence score. The operational requirement of MRI scanners for liquid helium is supported by industry sources, confirming the claim's accuracy.
Individual Claims
86
True
Technology
Quibim has launched the QP-Breast MRI tool in Europe and the UK for detecting breast cancer.
The claim is supported by multiple sources, including Imaging Technology News and Quibim's own website, confirming the launch of the QP-Breast MRI tool in Europe and the UK. The tool is CE and UKCA marked, indicating regulatory compliance.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
95
Web Consensus Weight
50
Source Quality Score
90
Source Quality Weight
25
Llm Reasoning Score
90
Llm Reasoning Weight
25
Weighted Total
86
Evidence Summary
2 web sources confirm the launch of QP-Breast in Europe and the UK.
83
True
Health
Breast cancer is the most commonly diagnosed cancer in women globally, with 2.3 million new cases each year.
The claim is corroborated by multiple authoritative sources, including Cancer Research UK and SEER, which confirm that breast cancer is the most commonly diagnosed cancer in women globally, with approximately 2.3 million new cases annually.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
90
Web Consensus Weight
50
Source Quality Score
85
Source Quality Weight
25
Llm Reasoning Score
90
Llm Reasoning Weight
25
Weighted Total
83
Evidence Summary
3 authoritative web sources confirm the global prevalence of breast cancer.
46
Mixed
Health
Up to 4 out of 5 biopsied breast lesions are not cancer.
The evidence provided does not directly confirm the claim that up to 4 out of 5 biopsied breast lesions are not cancer. The sources discuss biopsy techniques but do not provide specific statistics on the proportion of non-cancerous lesions.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
50
Web Consensus Weight
50
Source Quality Score
40
Source Quality Weight
25
Llm Reasoning Score
40
Llm Reasoning Weight
25
Weighted Total
46
Evidence Summary
No direct evidence found to confirm the specific statistic about non-cancerous biopsied lesions.
86
True
Regulation
QP-Breast is CE marked under EU MDR 2017/745 as a Class IIb medical device and UKCA marked as a Class IIa medical device.
The claim is supported by evidence from Quibim's website, which confirms that QP-Breast is CE marked under EU MDR 2017/745 as a Class IIb medical device and UKCA marked as a Class IIa medical device, indicating compliance with regulatory standards.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
95
Web Consensus Weight
50
Source Quality Score
90
Source Quality Weight
25
Llm Reasoning Score
90
Llm Reasoning Weight
25
Weighted Total
86
Evidence Summary
Quibim's website confirms CE and UKCA marking for QP-Breast.
79
Mostly True
Technology
MRI scanners require about 1,500 liters of liquid helium to operate.
The claim is supported by multiple sources, including RSNA and Radiology Business, which state that most MRI scanners require around 1,500 liters of liquid helium to operate. This is consistent with industry standards.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
85
Web Consensus Weight
50
Source Quality Score
80
Source Quality Weight
25
Llm Reasoning Score
85
Llm Reasoning Weight
25
Weighted Total
79
Evidence Summary
2 web sources confirm the helium requirement for MRI scanners.
